Hinge Health, Inc.
HNGE
$44.49
$0.451.02%
NYSE
| 06/30/2025 | |||||
|---|---|---|---|---|---|
| Revenue | 12.33% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 12.33% | ||||
| Cost of Revenue | 71.42% | ||||
| Gross Profit | -1.57% | ||||
| SG&A Expenses | 526.56% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 550.26% | ||||
| Operating Income | -4,520.46% | ||||
| Income Before Tax | -570.91% | ||||
| Income Tax Expenses | -132.67% | ||||
| Earnings from Continuing Operations | -574.52% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -574.52% | ||||
| EBIT | -4,520.46% | ||||
| EBITDA | -4,353.45% | ||||
| EPS Basic | -277.67% | ||||
| Normalized Basic EPS | -1,289.13% | ||||
| EPS Diluted | -277.67% | ||||
| Normalized Diluted EPS | -1,289.13% | ||||
| Average Basic Shares Outstanding | 167.07% | ||||
| Average Diluted Shares Outstanding | 167.07% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||